OTHER × Liver Neoplasms × Clear all
NCT06673329 2026-05-13

Brodalumab in the Treatment of Immune-Related Adverse Events

Columbia University

Phase 1 Recruiting
11 enrolled
NCT02012699 2026-05-05

iCaRe2

University of Nebraska

Recruiting
999,999 enrolled
NCT02333604 2026-04-23

CER

Cancer Support Community, Research and Training Institute, Philadelphia

Recruiting
15,000 enrolled